Peak's "Centennial" Ideal
Release time:
2020-07-31
Editor's Note: During the National Day, the "Jinhua New Observation" column of Jinhua TV Station launched a series of reports on "National Day New Observation: New Development of Old Enterprises" to understand those old enterprises that have grown up with New China in the new era. What kind of new development. 10# April 3 broadcast "Peak's 'Centennial Ideal" tells the development process and future development direction of Jianfeng Group.
Peak's "Centennial" Ideal
Jinhua TV Reporter Wang Dujuan Jiang Qian
Host: Speaking of Zhejiang Jianfeng Group Co., Ltd., Jinhua people are no stranger. The older generation of Jinhua people are more familiar with, may be the predecessor of Jianfeng Group-Jinhua Cement Factory.
Open the first old photo of 58 years ago, surrounded by mountains and a rice field in the middle. Old Jinhua can see at a glance that this is the Wise Temple east of Qianzhuangtou, Luodian Town, 8 kilometers from the north of Jinhua City. 1958 8 March, the first pioneers came here, with a pair of hands and a cavity of blood, built Jinhua's first cement plant on the desolate hillside of 16.94 mu.
From the earliest cattle ball forming machine to the electric ball forming machine, from pure manual labor to machine substitution, it took 26 years of hard work. By 1983 , the annual output of peak cement reached 12 tons, the output value reached 675 yuan, and the profit reached 240 yuan. In these 26 years, the cement plant experienced a difficult period of the country, the "Cultural Revolution" ten years of catastrophe, and finally ushered in a good time of reform and opening up with tenacious vitality, laying the foundation for steady development in the future.
Looking at these old photos, Jin Wengan, who entered the factory in 1970 , felt a lot. When he entered the gate of Jinhua cement factory, he was only 19 years old.
Jin Wengan, retired employee of Zhejiang Jianfeng Group Co., Ltd.: 42 , all at the peak. My lover is also at the peak, my son-in-law is also at the peak, and my brother-in-law is also at the peak. I can from a farmer to finally become a manager, science and technology personnel, are peak training.
Like Jin Wengan, Jiang Xiaomeng, chairman of Jianfeng Group, entered Jinhua Cement Factory after graduating from Senior high school. In the period of 36 , from an ordinary worker to the chairman of the group, Jiang Xiaomeng witnessed the development of Jinhua Cement Plant and now guides the transformation and upgrading of Jianfeng Group. In his view, the development of Jianfeng Group has encountered two most difficult periods. The first time was in the late 1980 s. Due to the limited scale and efficiency of the enterprise, it lacked funds for expansion and development. This hurdle prompted Jinhua Cement Plant to embark on the road of "horizontal integration", set up a cement group, and successfully carried out shareholding reform.
Jiang Xiaomeng, Chairman of Zhejiang Jianfeng Group Co., Ltd.: In Jinhua area, besides Phoenix Chemical, we are the second company officially listed on the Shanghai Stock Exchange. 1993 7 May 28 , we passed the shareholding system reform and became a listed company.
In 1993 , Peak Stock was listed on the Shanghai Stock Exchange, becoming the first listed company in the national cement industry. The stock code is 600668 . So far, the peak group still retains a sample of the stock. This stock sample also bears the signature of Du Zihong, the first-generation chairman of Jianfeng Group. Jiang Xiaomeng, Chairman of
Zhejiang Jianfeng Group Co., Ltd.: Jianfeng has gone from a single cement to absolute diversity. At most, he has made 21 kinds of products. Apart from medicine, cement and communication cables, we have done everything from mineral water and lighters to GPS system. Enterprise development will have such a process. But after the whole thing is done, you will finally focus on developing your own strengths, that is, what you can control and have the ability to do well.
In 2006 , a new crisis appeared in front of Jianfeng Group. Due to the overcapacity of cement industry losses, new investment enterprises can not play a benefit. The peak has shut down ten machine kiln production lines, with the courage of "strong men break their wrists" began to readjust the industrial layout.
Jiang Xiaomeng, Chairman of Zhejiang Jianfeng Group Co., Ltd.: We have taken the initiative to cooperate with central enterprises to convert this asset, which is relatively inefficient or inefficient in Zhejiang, into cash and invest it in the western region with more resources.
crises and sometimes opportunities. Starting from 1958 Jinhua Cement Plant, Jianfeng Group has created development opportunities and faced different development difficulties along the way. In the autumn of 2007 , Jianfeng Group took the initiative to join forces with China Building Materials Group to participate in the establishment of Southern Cement Company. Through forming a strategic alliance with central enterprises, Zhejiang cement market was integrated. In 2008 , Jianfeng Group transferred its center to places with resources and markets such as southwest and central China, successfully breaking out of the predicament.
Jiang Xiaomeng, Chairman of Zhejiang Jianfeng Group Co., Ltd.: At ordinary times, some research institutions call our business strategy "half-step philosophy", which means half a step ahead of others.
is under the guidance of this half-step philosophy. While doing a good job in the traditional cement industry, Jianfeng Group puts part of the company's focus on the development of the pharmaceutical industry. 1998 July, Zhejiang Jianfeng Pharmaceutical Co., Ltd. was established. After early market cultivation, starting from 2011 , Jianfeng Pharmaceutical introduced high-end intellectual resources, hired researcher Liu Jiajian, chief scientist of Sichuan Antibiotic Industry Research Institute, and his scientific research team, and set up Jinhua Academician Expert Workstation. This year upgraded to Zhejiang Province academician expert workstation.
Shi Cunyuan, Manager of Zhejiang Jianfeng Pharmaceutical Product Development Department: At present, we are working on 11 varieties, of which there are two national first-class innovative drugs, both of which are anti-tumor.
September 129, 2015 January, the high-tech enterprises declared by Jianfeng Group with Jianfeng Pharmaceutical Project were included in the second batch of "Three Projects" cultivation enterprises in Zhejiang Province. As of 2014 , the company has 22 valid patents for , including 21 136 for inventions, and its products are sold in 32 provinces, autonomous regions and municipalities directly under the central government in . In 2015 , the company realized sales of of 11 .3 billion yuan and paid taxes of of 5000 .45 million yuan.
At present, our Jianfeng Pharmaceutical products are mainly developed new drugs, accounting for more than 90% of the total sales volume, which is the benefit of new drug sales.
These are our main profitable varieties and also the main varieties, with considerable originality.
, Jianfeng Group integrated authoritative achievements at home and abroad and relevant resources in the enterprise to enter the big health industry.
countries now advocate moving from "treatment of existing diseases" to "preventive treatment of diseases", and the 12th Five-Year Plan for Great Health has also been released. So what does "preventive treatment" depend on? It depends on our medical treatment and health care, and prevention before disease. Therefore, we follow this logic to lay out the big health industry. Jinhua area has regional advantages and transportation advantages. On the basis of the original bonded logistics, we not only do a good job in bonded logistics, but also develop in the direction of e-commerce and third-party logistics. This will form a "two-wheel drive, two wings fly together" industrial layout.
60 years. Generations of employees have grown up alternately with the enterprise. Young employees are still working hard, and retired employees are also hard to give up. Jin Wengan, who never wanted to leave, left the enterprise after retiring in 2012 . When he had nothing to do, he would always look through the old photos and look back at that year.
As soon as I arrive in Jiangbei, I will visit our company. After all, it has been 42 years.
Jianfeng has today's development, first, thanks to our own inherent driving force for strong development; Second, there is a team that is diligent and conscientious and has worked hard for the past generations. Third, there is a good mechanism and system. Fourth, there is a good corporate culture and we have common values, there is a culture that everyone agrees. Only in this way can enterprises achieve everlasting foundation and a hundred years of peak.
years of ups and downs, the difficulties and crises experienced by enterprises, we can only look back, but can not empathize. But from the old photos, from the wrinkles on the faces of retired employees, we can see a giant with a tall and straight body, firm eyes, and steady steps. His face has left traces of time, and his eyes are still burning. Looking into the distance.
http://tv1.jinhua.com.cn/jhxgc/2016-10-03/223310.html
(top)(bottom)More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31